These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23612203)

  • 1. Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.
    Issaka M; Salissou A; Arzika I; Guillebaud J; Maazou A; Specht S; Zamanka H; Fandeur T
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3415-9. PubMed ID: 23612203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained
    Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing Antimalarial Drug Sensitivities in Uganda.
    Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
    Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
    Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
    Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Agarwal P; Anvikar AR; Pillai CR; Srivastava K
    Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
    ; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
    N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of combination antimalarial therapies in children from Papua New Guinea.
    Karunajeewa HA; Mueller I; Senn M; Lin E; Law I; Gomorrai PS; Oa O; Griffin S; Kotab K; Suano P; Tarongka N; Ura A; Lautu D; Page-Sharp M; Wong R; Salman S; Siba P; Ilett KF; Davis TM
    N Engl J Med; 2008 Dec; 359(24):2545-57. PubMed ID: 19064624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum population-level use of artemisinin combination therapies: a modelling study.
    Nguyen TD; Olliaro P; Dondorp AM; Baird JK; Lam HM; Farrar J; Thwaites GE; White NJ; Boni MF
    Lancet Glob Health; 2015 Dec; 3(12):e758-66. PubMed ID: 26545449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
    Zhou LJ; Xia J; Wei HX; Liu XJ; Peng HJ
    Parasitol Res; 2017 Feb; 116(2):781-788. PubMed ID: 28028628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance.
    Okafor HU; Shu EN; Oguonu T
    J Trop Pediatr; 2010 Dec; 56(6):398-406. PubMed ID: 20144932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malariological baseline survey and in vitro antimalarial drug resistance in Gulu district, Northern Uganda.
    Prugger C; Engl M; Ogwang M; Ploner F; Ploner M; Gluderer D; Wernsdorfer G; Wernsdorfer WH;
    Wien Klin Wochenschr; 2008; 120(19-20 Suppl 4):63-8. PubMed ID: 19066776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.